Apple watch patent dispute: judge rules new models don't infringe, but battle continues

A legal battle between Apple and Masimo over blood-oxygen monitoring Technology continues to unfold, with a recent ruling offering a temporary reprieve for the tech giant. An International Trade Commission (ITC) judge has determined that redesigned Apple Watch models do not violate Masimo's patents, a significant development after previous setbacks.

The long-running dispute between apple and masimo has taken a new turn.

The core of the issue revolves around pulse-oximetry Technology, which Masimo alleges Apple acquired through the recruitment of its engineers. In December 2023, the ITC initially ruled that several Apple Watch models, including the Apple Watch Series 9 and Ultra 2, infringed on Masimo's patents, leading to a US import ban. Apple responded by removing the blood-oxygen monitoring feature and later reintroducing it with processing done on connected iPhones, not directly on the watch.

However, the ITC judge's decision suggests a shift in the legal landscape. While the ruling is a victory for Apple, it's not the final word. The full commission of the ITC must now review the judge's findings before a definitive decision is reached. Adding to the complexity, the US Court of Appeals for the Federal Circuit upheld the 2023 ruling against Apple's older watch design.

Apple has publicly stated its satisfaction with the ITC's decision but indicated it will explore